Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...
News-Medical.Net on MSN
Metabolic BMI reveals hidden health risks in normal weight individuals
People of normal weight may also be at risk of diabetes and similar diseases. A study from the University of Gothenburg ...
In TODAY.com's Expert Tip of the Day, a dietitian recommends a breakfast for women trying to lose weight in the years leading ...
8hon MSN
Weight Loss Drug Wegovy Is Now Available in Pill Form—Here‘s What a Doctor Wants You to Know
The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...
People on average regain weight at a rate of 0.4 kg/month after they stopped taking their weight loss medications, a review ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...
People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...
Verywell Health on MSN
11 Common Reasons Your Weight Changes From Day to Day
Weight fluctuation happens daily, week to week, or month to month. Learn about causes and when to see a healthcare provider about weight changes.
"That’s surprisingly quick – almost four times faster than the weight regain seen after stopping weight-loss programmes based ...
Researchers at Leipzig University and the University of Gothenburg have developed a novel approach to assessing an individual ...
People who stop taking weight-loss jabs such as Wegovy regain pounds much faster than those who halt exercising and dieting, ...
4don MSN
Less than two years after stopping obesity drugs, weight and health issues return, study finds
The retrospective study could not determine whether some patients were more likely than others to keep off the weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results